Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study
Ublituximab治疗多发性硬化症五年:ULTIMATE I 和 II 开放标签扩展研究
期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2026.0007
Cree, Bruce A C; Fox, Edward; Hartung, Hans-Peter; Alvarez, Enrique; Qian, Peiqing; Wray, Sibyl; Robertson, Derrick; Selmaj, Krzysztof; Wynn, Daniel; Mok, Koby; Rowland, Chris; Bodhinathan, Karthik; Sportelli, Peter; Miskin, Hari P; Steinman, Lawrence